NEW YORK, April 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
SAN FRANCISCO, CA, April 01, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (OTC: PRSI) ("Portsmouth Square" or "the Company") today…
Tech Solutions Provider Becomes Official Partner for the Bay Area's Team Through the 2026 Major League Cricket Season LONDON, March…
SAN FRANCISCO, Feb. 23, 2025 (GLOBE NEWSWIRE) -- Bay Area Therapy Center is excited to announce an enhanced focus on…
SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- In a remarkable display of resilience and determination, Ivy En Rose MedSpa…
An Esteemed Arts Executive and Trailblazing Asian Art Scholar, Lee will Serve as the Institution's Next Barbara Bass Bakar Director and…
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival (OS) among patients with HR+, HER2- advanced breast…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
